acut
exacerb
signific
event
cours
chronic
obstruct
pulmonari
diseas
modern
diagnost
techniqu
reveal
infecti
caus
major
exacerb
common
respiratori
virus
contribut
exacerb
detect
viral
nucleic
acid
nasopharyng
swab
sputum
sampl
becom
prefer
method
studi
viral
exacerb
instead
viral
cultur
serolog
examin
clinic
applic
molecular
detect
requir
addit
studi
clarifi
interpret
posit
result
bacteria
account
exacerb
studi
compar
molecular
detect
bacteria
sputum
convent
cultur
techniqu
shown
substanti
proport
bacteria
detect
latter
method
howev
molecular
viral
detect
clinic
applic
molecular
bacteri
diagnosi
requir
addit
studi
although
still
face
sever
challeng
requir
addit
develop
quit
like
molecular
method
becom
prefer
method
determin
etiolog
exacerb
chronic
obstruct
pulmonari
diseas
cours
chronic
obstruct
pulmonari
diseas
copd
character
period
episod
increas
respiratori
dyspnea
cough
sputum
product
chest
discomfort
system
fatigu
sleep
disturb
lowgrad
fever
symptom
clinic
diagnos
exacerb
although
poorli
character
past
recent
investig
clarifi
signific
etiolog
pathogenesi
exacerb
landmark
longitudin
studi
relationship
found
loss
lung
function
frequenc
copd
exacerb
recent
studi
disput
earlier
result
exacerb
lead
caus
death
advanc
copd
associ
rapid
declin
qualiti
life
patient
copd
result
hospit
account
cost
care
copd
copd
recogn
inflammatori
diseas
airway
parenchyma
lung
exacerb
character
acut
inflammatori
event
superimpos
background
chronic
inflamm
excess
inflamm
increas
airway
obstruct
induc
bronchoconstrict
excess
mucu
product
airway
edema
translat
cardin
clinic
symptom
dyspnea
cough
sputum
product
mani
patient
copd
symptom
stabl
baselin
statu
patient
increas
symptom
beyond
usual
day
day
variabl
defin
exacerb
recent
work
develop
patientreport
symptom
tool
measur
exacerb
shown
focu
cardin
symptom
narrow
nk
leidi
unpublish
data
addit
import
symptom
exacerb
describ
patient
includ
chest
discomfort
fatigu
sleep
disturb
sputum
purul
also
common
often
cue
patient
seek
health
care
interest
patient
seek
health
care
half
episod
meet
definit
exacerb
copd
report
exacerb
unreport
episod
milder
report
exacerb
still
signific
long
termimpact
cours
copd
typic
cours
exacerb
subacut
onset
day
peak
follow
gradual
resolut
day
suggest
infecti
process
use
modern
diagnost
techniqu
clear
major
exacerb
infecti
origin
tabl
current
estim
approxim
onequart
exacerb
viral
caus
onequart
bacteri
etiolog
onequart
result
combin
pathogen
caus
exacerb
remain
unclear
episod
appear
relat
environment
irrit
exposur
viral
bacteri
pathogen
associ
exacerb
share
sever
common
characterist
tropism
upper
airway
healthi
human
host
primari
mode
transmiss
human
human
usual
asymptomat
colon
upper
airway
glotti
caus
mild
infect
patient
without
copd
innat
defens
mechan
keep
lower
airway
steril
spite
repeat
inhal
microaspir
bacteria
virus
context
copd
innat
lung
defens
system
damag
subsequ
increas
risk
microbi
colon
extend
lower
subglott
airway
pathogen
presenc
lower
airway
stimul
host
immuneinflammatori
respons
attempt
erad
pathogen
inflammatori
respons
caus
symptom
exacerb
contribut
progress
airway
damag
furthermor
effect
adapt
immun
respons
follow
exacerb
often
help
straintostrain
heterogen
sever
studi
done
document
viral
etiolog
copd
exacerb
studi
reli
viral
cultur
serolog
find
tabl
techniqu
respiratori
viru
associ
exacerb
contrast
patient
copd
studi
stabl
period
viral
isol
serolog
convers
found
major
drawback
older
studi
sever
recent
studi
relianc
nasopharyng
np
sampl
viral
cultur
may
discord
presenc
viru
np
viru
lower
respiratori
tract
presenc
viru
specif
increas
antibodi
titer
convalesc
serum
sampl
support
evid
infect
posit
serolog
respons
could
occur
viral
upper
airway
infect
therefor
although
earlier
studi
support
viral
causat
exacerb
presum
np
cultur
result
indic
infect
tracheobronchi
tree
increas
antibodi
titer
reflect
lower
upper
airway
infect
introduct
polymeras
chain
reaction
pcr
method
usher
new
wave
studi
examin
viral
causat
exacerb
copd
studi
report
presenc
viral
nucleic
acid
exacerb
beckham
et
al
found
virus
cultur
upper
airway
sampl
obtain
studi
adult
respiratori
ill
includ
exacerb
copd
sampl
subject
reversetranscriptas
pcr
rtpcr
viral
nucleic
acid
detect
viral
yield
increas
studi
highest
rate
detect
higher
rate
detect
subsequ
stabl
state
sampl
also
seen
spectrum
viral
pathogen
detect
molecular
techniqu
similar
seen
cultur
earlier
studi
except
newli
discov
virus
human
metapneumoviru
rel
frequenc
virus
also
chang
influenza
detect
less
often
rsv
detect
often
redistribut
could
reflect
chang
method
detect
chang
preval
result
influenza
vaccin
interest
detect
viral
nucleic
acid
higher
use
sputum
oppos
np
sampl
site
simultan
sampl
sputum
sampl
consid
repres
lower
airway
infect
nasopharyng
sampl
provid
sampl
meet
qualiti
criteria
leukocyt
epitheli
cell
per
lowpow
field
molecular
detect
viru
sputum
sensit
specif
less
traumat
np
swab
specimen
problem
interpret
result
investig
conclud
presenc
viral
nucleic
acid
detect
pcr
sputum
sampl
impli
prove
infect
viru
pcr
detect
copi
target
respiratori
viru
whether
low
viral
titer
patholog
signific
unclear
borg
et
al
quantifi
respiratori
syncyti
viru
respiratori
secret
use
realtim
rtpcr
children
acut
respiratori
tract
infect
adult
copd
viral
quantit
vari
fold
vs
viral
titer
equal
low
stabl
exacerb
copd
pcr
detect
dead
live
viru
invas
diseas
prolong
asymptomat
shed
quantit
may
help
defin
invas
diseas
anoth
limit
pcr
studi
lack
immunolog
assay
determin
presenc
absenc
antibodi
marker
host
respons
might
help
papi
et
al
report
sputum
eosinophilia
virus
detect
pcr
sputum
exacerb
studi
increas
level
sputum
report
use
molecular
detect
viru
molecular
detect
viral
pathogen
like
becom
diagnost
method
choic
exacerb
copd
rapid
conveni
sensit
compar
cultur
develop
new
antivir
drug
spur
use
molecular
diagnosi
clinic
set
happen
need
ascertain
follow
research
set
quantit
pcr
rather
qualit
pcr
necessari
time
exacerb
distinguish
extrem
low
titer
like
noninvas
viru
higher
concentr
seen
infect
technic
perform
prior
studi
attempt
determin
extent
bacteri
causat
exacerb
copd
unsuccess
bacteria
colon
tracheobronchi
tree
stabl
copd
therefor
simpli
detect
bacteria
sputum
sampl
patient
copd
differenti
colon
infect
shown
earli
studi
bacteriolog
sputum
copd
howev
use
molecular
epidemiolog
possibl
differenti
newli
acquir
strain
preexist
colon
strain
bacteri
pathogen
clear
relationship
acquisit
new
strain
exacerb
copd
furthermor
exacerb
new
strain
associ
mucos
system
immun
respons
infect
strain
strongli
associ
neutrophil
inflammatori
profil
sputum
studi
clearli
establish
nontyp
haemophilu
influenza
nthi
streptococcu
pneumonia
moraxella
catarrhali
pseudomona
aeruginosa
caus
signific
proport
copd
exacerb
observ
date
base
use
sputum
cultur
identifi
presenc
bacteri
infect
sputum
cultur
alon
reflect
scope
bacteri
infect
copd
evid
came
studi
nthi
dynam
stabl
copd
monthli
sputum
cultur
perform
cours
prospect
longitudin
studi
involv
cohort
patient
stabl
copd
strain
nthi
recur
sputum
despit
prolong
period
nondetect
sputum
cultur
unclear
whether
repres
reinfect
nthi
strain
possibl
strain
never
elimin
sputum
sputum
cultur
insensit
detect
adequaci
lower
airway
sampl
document
measur
fibrinogen
cultureneg
posit
sputum
sampl
molecular
detect
nthi
base
pcr
sequenc
gene
perform
nthi
found
cultureneg
sputum
sampl
gap
figur
furthermor
strain
nthi
detect
molecular
techniqu
gap
strain
nthi
isol
cultur
end
gap
p
aeruginosa
dynam
colon
examin
studi
cultureneg
sputum
sampl
molecular
detect
opa
gene
p
aeruginosa
present
therefor
sputum
cultur
limit
abil
detect
bacteri
pathogen
stabl
copd
whether
limit
extend
exacerb
copd
systemat
examin
observ
consist
data
respiratori
infect
otiti
media
pneumonia
detect
bacteria
nthi
catarrhali
pneumonia
enhanc
use
molecular
detect
bacteria
curran
et
al
evalu
induc
sputum
sampl
obtain
patient
copd
control
patient
nest
realtim
pcr
sensit
cultur
detect
varieti
typic
atyp
pathogen
method
includ
use
nest
rather
pcr
thu
greater
risk
contamin
inabl
quantit
also
use
pli
gene
pneumonia
gene
nthi
known
lack
specif
pathogen
antibiot
wide
use
acut
exacerb
copd
rapid
inexpens
valid
techniqu
molecular
detect
bacteria
avail
would
clinic
embrac
enhanc
stewardship
antibiot
use
howev
viral
detect
sever
question
aris
posit
pcr
result
separ
colon
infect
quantit
threshold
defin
infect
airway
system
inflammatori
profil
exacerb
pathogen
detect
molecular
techniqu
similar
seen
bacteria
detect
cultur
detect
molecular
method
associ
immun
respons
similar
seen
bacteria
isol
cultur
practic
limit
molecular
detect
isol
molecular
epidemiolog
difficulti
surmount
pcr
sequenc
select
gene
heterogen
strain
speci
gene
nthi
howev
would
increas
complex
turnaround
time
molecular
detect
determin
specif
antibodi
respons
exacerb
best
done
homolog
strain
circumv
use
pool
heterolog
strain
test
antigen
final
isol
antibiot
suscept
test
organ
possibl
test
gene
respons
antibiot
resist
use
rrnabas
microarray
termin
restrict
fragmentlength
polymorph
techniqu
emerg
applic
better
character
airway
microbiota
copd
exacerb
studi
excit
new
field
would
enabl
us
get
even
better
understand
microbiolog
copd
exacerb
